As BRAF and FGFR1 mutations are typical hallmarks of low-grade gliomas/glioneuronal tumours such as ganglioglioma or pilocytic astrocytoma, the co-occurrence of H3-K27 and these MAPK alterations makes diagnosis and grading difficult [30]. The gene discussed is BRAF; the disease is ganglioglioma.